Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
SNAQ is a Swiss digital health company focused on diabetes meal tracking and glycemic management. Its core product is an AI-powered mobile app that estimates carbohydrates and other nutritional values from meal photos and links those data with glucose sensor, insulin, and activity information. The company also offers a provider-facing remote care product designed to help clinicians identify patients with suboptimal mealtime glucose control and personalize interventions. SNAQ appears to commercialize software rather than therapeutics, and its business is positioned at the intersection of diabetes management, computer vision, and connected care.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on SNAQ.